Growth Metrics

BeOne Medicines (ONC) Other financing activities (2016 - 2024)

BeOne Medicines (ONC) has disclosed Other financing activities for 4 consecutive years, with $23.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities changed N/A to $23.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.4 million, a N/A change, with the full-year FY2025 number at $23.4 million, up 679.73% from a year prior.
  • Other financing activities was $23.4 million for Q4 2025 at BeOne Medicines, up from $4.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $23.4 million in Q4 2025 to a low of $23.4 million in Q4 2025.